ADB COMBINATION FOR USE IN HCV TREATMENT

• 收藏
• 分享

专利权人:

ABBVIE INC.

发明人:

BERNSTEIN, BARRY, M.,MENON, RAJEEV, M.,KHATRI, AMIT,MENSING, SVEN,DUTTA, SANDEEP,COHEN, DANIEL, E.,PODSADECKI, THOMAS, J.,BRUN, SCOTT, C.,AWNI, WALID, M,DUMAS, EMILY, O.,KLEIN, CHERI, E.

申请号：

ES201490005

公开号：

ES2529144R1

申请日:

2012.10.19

申请国别(地区):

ES

年份:

2015

代理人:

摘要：

AAD combination for use in treating HCV. # The present invention provides combinations of antiviral agents for use in therapy without interferon and ribavirin in the treatment of HCV. Preferably the treatment is for a short treatment time, such as no more than 12 weeks. In one aspect, the use of combinations of antiviral agents in therapy comprises administering at least two direct-acting antiviral agents without interferon and ribavirin to a subject with HCV infection.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/